Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | thioredoxin reductase, putative | 0.005 | 0.2539 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.0877 | 0.3702 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0038 | 0.1707 | 0.7204 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0017 | 0.0312 | 0.5 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0036 | 0.154 | 0.6498 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0017 | 0.0312 | 0.0408 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.1047 | 0.4418 |
Mycobacterium tuberculosis | Probable reductase | 0.0115 | 0.6905 | 0.8837 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0036 | 0.154 | 0.6498 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0017 | 0.0312 | 0.1316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0029 | 0.1066 | 0.4499 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0128 | 0.7773 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.005 | 0.2539 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0017 | 0.0312 | 0.0408 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0017 | 0.0312 | 0.0408 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0048 | 0.237 | 0.9272 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0017 | 0.0312 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0036 | 0.154 | 0.6498 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0036 | 0.154 | 0.6498 |
Treponema pallidum | NADH oxidase | 0.0017 | 0.0312 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0029 | 0.1066 | 0.4499 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.237 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.237 | 1 |
Plasmodium falciparum | glutathione reductase | 0.005 | 0.2539 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0048 | 0.237 | 0.9272 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0048 | 0.237 | 0.9272 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.088 | 0.3713 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0115 | 0.6905 | 0.8837 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0048 | 0.237 | 0.9272 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0038 | 0.1707 | 0.7204 |
Toxoplasma gondii | thioredoxin reductase | 0.005 | 0.2539 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0038 | 0.1707 | 0.7204 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.088 | 0.3713 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0038 | 0.1707 | 0.7204 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.005 | 0.2539 | 1 |
Brugia malayi | glutathione reductase | 0.005 | 0.2539 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.005 | 0.2539 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0128 | 0.7773 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.005 | 0.2539 | 0.2985 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0029 | 0.1066 | 0.4499 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0038 | 0.171 | 0.6429 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.088 | 0.3713 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0048 | 0.237 | 0.9272 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.0877 | 0.3702 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0115 | 0.6905 | 0.8837 |
Plasmodium vivax | glutathione reductase, putative | 0.005 | 0.2539 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0036 | 0.154 | 0.5514 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0017 | 0.0312 | 0.1316 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.005 | 0.2539 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0036 | 0.154 | 0.6498 |
Plasmodium falciparum | thioredoxin reductase | 0.005 | 0.2539 | 1 |
Giardia lamblia | GTOR | 0.0048 | 0.237 | 1 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0017 | 0.0312 | 0.0408 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Loa Loa (eye worm) | thioredoxin reductase | 0.005 | 0.2539 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0023 | 0.0663 | 0.1919 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0016 | 0.0217 | 0.0916 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Leishmania major | trypanothione reductase | 0.005 | 0.2539 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0017 | 0.0312 | 0.5 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0115 | 0.6905 | 0.8837 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0036 | 0.154 | 0.6498 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0048 | 0.237 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0016 | 0.0217 | 0.0916 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0017 | 0.0312 | 0.0408 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0017 | 0.0312 | 0.5 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0048 | 0.237 | 0.9272 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.1047 | 0.4418 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0017 | 0.0312 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.0877 | 0.3702 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0031 | 0.1234 | 0.5205 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0041 | 0.1896 | 0.8002 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0017 | 0.0312 | 0.0408 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0115 | 0.6905 | 0.8837 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0048 | 0.237 | 0.9272 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0017 | 0.0312 | 0.0097 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.237 | 1 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0038 | 0.171 | 0.6429 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0016 | 0.0217 | 0.0916 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0016 | 0.0217 | 0.0916 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0017 | 0.0312 | 0.5 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.005 | 0.2539 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0128 | 0.7773 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0048 | 0.237 | 0.2201 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.002 | 0.0476 | 0.1116 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0048 | 0.237 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0032 | 0.1304 | 0.5501 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0048 | 0.237 | 0.9272 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0115 | 0.6905 | 0.8837 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0048 | 0.237 | 0.9272 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.088 | 0.3713 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0048 | 0.237 | 0.9272 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0128 | 0.7773 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0016 | 0.0217 | 0.0916 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0038 | 0.171 | 0.6429 |
Brugia malayi | Thioredoxin reductase | 0.005 | 0.2539 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0017 | 0.0312 | 0.0408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0036 | 0.154 | 0.6498 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0038 | 0.1707 | 0.7204 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.